Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.

NCT03798236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: PBF-1650 oral capsules
DRUG: Placebo oral capsule

Sponsor

Palobiofarma SL

Collaborators

[object Object]